Name:hCD45-F Sequence:CTT CAG TGG TCC CAT TGT GGT G Product:25 nmole DNA Oligo Purification:Standard… and 7 more items

Integrated DNA Technologies Inc. received a purchase order (PO-0466362) from the University of Virginia for the procurement of synthetic DNA oligonucleotides. The award was executed on August 6, 2026, with a cumulative contract value of $43.00. The contract encompasses eight distinct DNA oligo products, each specified at a 25 nanomole concentration with standard desalting purification. The oligonucleotides include forward and reverse primers targeting human genes associated with immune and cellular functions: CD45, CD14, CSF1R (Colony Stimulating Factor 1 Receptor), and DCSTAMP (Dendritic Cell-Specific Transmembrane Protein). Unit prices for individual line items range from $4.47 to $6.89, with pricing correlated to sequence length and base composition.

All deliverables are designated for receipt by Jarred M Whitlock at the University of Virginia, located in Virginia. The contract represents a research-support acquisition typical of academic institutional procurements for molecular biology applications. No specific period of performance or completion date is indicated in the documentation provided. As a Virginia-based contracting organization, the University of Virginia executed this purchase order through its procurement authority for materials supporting research and instructional activities.